MediWound Ltd. MDWD
$13.56
+0.22%
at last close
Analyst Consensus
- Consensus Rating
- Buy (2 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $33.00
- Implied Upside
- +143.4%
- Price Target Range
- $30.00 – $36.00
- Analysts (12 mo)
- 2
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-14 | OppenheimerJeff Jones |
Maintains | Outperform | $32 → $30 |
| 2026-05-28 | OppenheimerFrancois Brisebois |
Maintains | Outperform | $33 → $32 |
| 2026-05-28 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $36 |
| 2025-11-21 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $31 → $36 |
| 2025-05-22 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $25 → $31 |
| 2025-03-20 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $25 |
| 2025-02-28 | Craig-HallumChase Knickerbocker |
Initiates coverage on | Buy | $39 |
| 2025-01-10 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $25 |
| 2024-11-27 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $28 → $25 |
| 2024-10-11 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $28 |
| 2024-08-15 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $28 |
| 2024-07-16 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $28 |
| 2024-05-30 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $28 |
| 2024-03-22 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $28 |
| 2024-01-16 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $26 → $28 |
| 2023-11-22 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $26 |
| 2023-09-21 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $23 → $26 |
| 2023-08-17 | OppenheimerFrancois Brisebois |
Maintains | Outperform | $63 → $36 |
| 2023-08-17 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $23 |
| 2023-05-31 | OppenheimerFrancois Brisebois |
Reiterates | Outperform | $63 |
| 2023-05-31 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $23 |
| 2023-03-17 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $23 |
| 2023-01-04 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $6 → $23 |
| 2022-12-30 | Cowen & Co.Joshua Jennings |
Maintains | Outperform | $6 → $25 |
| 2022-12-22 | Maxim GroupMichael Okunewitch |
Initiates coverage on | Buy | $25 |
| 2022-12-21 | OppenheimerFrancois Brisebois |
Maintains | Outperform | $9 → $63 |
| 2022-11-16 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $42 → $39 |
| 2022-07-18 | OppenheimerFrancois Brisebois |
Assumes | Outperform | $49 |
| 2022-05-18 | Wells FargoJacob Hughes |
Maintains | Overweight | $49 → $56 |
| 2022-03-21 | Aegis CapitalNathan Weinstein |
Maintains | Buy | $63 → $49 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $13.56
- Market Cap
- $178.77 million
- 52-Week Range
- $13.40 – $21.23
- Average Volume
- 69K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.